Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Replication deficient influenza virus for the expression of heterologous sequences

Replication deficient influenza virus for the expression of heterologous sequences

US Patent 9187732 · Granted Nov 17, 2015

Estimated economic value: $220,018,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prime-boost influenza vaccine2025
Recombinant high growth rate influenza virus comprising mutations in M1, NS2, an2025
Recombinant high growth rate influenza virus comprising mutations in M1, NS2, an2025
SO3 chromatography for use in a method for virus purification2022
Method for influenza virus purification2020
Influenza virus vector for virotherapy2019
Influenza virus vector for virotherapy2019
Influenza virus vector for virotherapy2018
Influenza virus2017
Influenza virus2017
Influenza virus2017
Attenuated negative strand viruses with altered interferon antagonist activity f2016